-
Free trial of state of the art data room for all downloaders of our IP protection in
#outlicensing webinar - http://ow.ly/l8aCz -
We Assisted
@cynatastemcells in the#OutLicensing of#Cymerus™ Technology to#FUJIFILM http://www.plexusventures.com/news/press_detail.php?pr=106 …#stemcells#regenmed#MSC -
@PhaxPharma - interested in#acquisition of mature#pharmaceutical products for the UK market#divestment#outlicensing -
Looking to monetize your patent portfolio? Let us meet to see in action how AI and ML can help commercialize your portfolio by predicting Gold patents against your competitors.
#PIFC#Tokyo#Conference#insights#Patdigger#GoldPatents#Monetization#Outlicensing pic.twitter.com/fzz7FJ4DRU
-
Pharmaceutical Intellectual Property Rights Webinar
#Outlicensing#IPProtection http://www.pharma-iq.com/regulatory-legal/webinars/outlicensing-and-beyond/ … -
The sale of the three drugs comes as Novartis is in the midst of a streamlining effort, second only to AstraZeneca in the number of divestments and out-licensing deals last year, according to analysts.
#Outlicensing|#Transformation|#PharmaForecast via@PharmaPhorumhttps://twitter.com/pharmaphorum/status/1150682775227437058 …
-
#TaiwanJ#Pharmaceuticals out-licenses#liver drug candidate in#Asia https://www.pharmaceutical-business-review.com/news/taiwanj-pharmaceuticals-obtained-26m-deal-for-licensing-and-co-development-contract-with-newsoara-biopharma-on-jkb-122-asian-rights/ … via@Pharma_BR#outlicensing#Newsoara#JKB122#NAFLD#NASH -
RT
@SO_Alyuna Inserm Transfert and CNRS Innovation will be exhibiting together at MedFIT, from June 26th to 27th in Strasbourg (stands A6 & B6).#MedTech#innovation#partnerships#outlicensing#MedFIT https://buff.ly/2ywWgAr pic.twitter.com/viRibG62BG
-
#CaraTherapeutics out-licenses#Korsuva#injection ex-US rights to#ViforFresenius for $520m …http://drugdiscovery.pharmaceutical-business-review.com/news/cara-licenses-korsuva-injection-ex-us-rights-to-vfmcrp-in-520m-deal-240518-6163384 …@Pharma_BR#outlicensing#licensingrights#CR845#difelikefalin#pain#itching -
Plexus Ventures Assists Fujifilm Kyowa Kirin Biologics in Partnering with Mylan of Humira® Biosimilar http://www.plexusventures.com/news/press_detail.php?pr=130 …
#Humira®#biosimilar#FujifilmKyowaKirinBiologics#Mylan#partnering#adalimumab#outlicensing -
#Outlicensing und#DueDiligence im Biotech- und Pharmaumfeld – mit der passenden Software, gelingt’s sicherhttps://hubs.ly/H0bb6xw0 -
The 3 Day
#workshop is suitable for businesses that: Either planning for or currently actively considering partnering/co-development as well as commercial opportunities, e.g#outlicensing, regional/global#clinicaltrials, engaging with Chinese#CRO/#CDMO.. http://georgejamesltd.com/training/china-workshops/3-day-china-workshop-developing-plan/ …pic.twitter.com/VRhPXpB2lC
-
Do you know how to ensure a successful deal with a partner in
#pharma or#biotech? Learn how to easily prepare a series of#outlicensing presentations from start to finish by enrolling in Carlos's online course: http://bit.ly/2Ev7qo6 pic.twitter.com/s9eGIOntO2
-
We Assisted
#CelonPharma &#Polfarmex in#OutLicensing of#Generic Advair® Diskus® for#France http://www.plexusventures.com/news/press_detail.php?pr=107 …#Salmex#Orbicel -
We are looking forward to have collaboration for
#InLicensing and#Outlicensing of Pharma#Dossiers /#Contract#Manufacturing. -
Traspaso de riesgos, market access o red de ventas limitada son razones para el #OutLicensing http://bit.ly/1Rjlfng
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.